VALIDITY EXPIRED personal data approved: 2009. IV. 07. Publications |
2009
manual entry, 2010. X. 01. |
Manciaa,G., Laurent,S., Agabiti-Rosei,E., Ambrosioni E., Burniere,M., Caulfield,M.J., Cifkova,R., Clement,D., Coca,A., Dominiczak,A., Erdine,S.,: Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task, J. Hypertens, pp. 2121-2158 type of document: Journal paper/Article impact factor: 5.800 language: English
|
2008
manual entry, 2010. X. 01. |
Kjeldsen, S.E., Lisa Naditch-Brule, Perlini S, Zidek W, and Farsang,C.: Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the GOOD survey., J. Hypertens, pp. 2064-2070 type of document: Journal paper/Article impact factor: 5.100 language: English
|
2007
manual entry, 2009. IV. 07. |
Mancia G., de Backer G, Dominiczak A….Farsang C: 2007 Guidelines fir the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of hypertension (ESH) and the European Society of Cardiology (ESC)., J. Hypertension, pp. 1105-1187 type of document: Journal paper/Review paper impact factor: 5.150 language: English
|
2004
manual entry, |
Papademetriou V, Farsang C, Elmfeldt D, Hofman A, Lithell H, Olofsson B, Skoog I, Trenkwalder P, Zanchetti A: Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension - The study on cognition a, J AM COLL CARDIOL 44: 1175-1180 (2004) type of document: Journal paper impact factor: 9.130 number of independent citations: 25
|
2003
manual entry, |
Mancia G, Rosei E A, Cifkova R, Debacker G, Erdine S, Fagard R, Farsang C, Heagerty A M, Kawecka Jaszcs K, Kiowski W, Kjeldsen S, Luscher T, Mcinnes G, Mallion J M, Brien E O, Poulter N R, Priori S G,: 2003 European society of hypertension - European Society of Cardiology guidelines for the management of arterial hypertension, J HYPERTENS 21: 1011-1053 (2003) type of document: Journal paper impact factor: 3.570
|
2003
manual entry, |
Tonstad S, Farsang C, Klaene G, Lewis K, Manolis A, Perruchoud A P, Silagy C, van Spiegel P I, Astbury C, Hider A, Sweet R: Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study, EUR HEART J 24: 946-955 (2003) type of document: Journal paper impact factor: 5.990 number of independent citations: 23
|
1982
manual entry, |
Farsang C, Kapocsi J, Juhasz I, Kunos G: POSSIBLE INVOLVEMENT OF AN ENDOGENOUS OPIOID IN THE ANTIHYPERTENSIVE EFFECT OF CLONIDINE IN PATIENTS WITH ESSENTIAL-HYPERTENSION, CIRCULATION 66: 1268-1272 (1982) type of document: Journal paper impact factor: 6.850 number of independent citations: 46
|
1981
manual entry, |
Kunos G, Farsang C, Ramirezgonzales M D: BETA-ENDORPHIN - POSSIBLE INVOLVEMENT IN THE ANTIHYPERTENSIVE EFFECT OF CENTRAL ALPHA-RECEPTOR ACTIVATION, SCIENCE 211: 82-84 (1981) type of document: Journal paper impact factor: 6.240 number of independent citations: 169
|
1980
manual entry, |
Farsang C, Ramirezgonzalez M D, Mucci L, Kunos G: POSSIBLE ROLE OF AN ENDOGENOUS OPIATE IN THE CARDIOVASCULAR EFFECTS OF CENTRAL ALPHA ADRENOCEPTOR STIMULATION IN SPONTANEOUSLY HYPERTENSIVE RATS, J PHARMACOL EXP THER 214: 203-208 (1980) type of document: Journal paper impact factor: 3.280 number of independent citations: 143
|
1979
manual entry, |
Farsang C, Kunos G: NALOXONE REVERSES THE ANTIHYPERTENSIVE EFFECT OF CLONIDINE, BRIT J PHARMACOL 67: 161-164 (1979) type of document: Journal paper impact factor: 4.620 number of independent citations: 161
|
| Number of independent citations to these publications: | 567 |
|
|